Tranexamic Acid in K-Beauty: What It Does and How It Compares

I added a tranexamic acid serum to my routine because I had a post-inflammatory dark spot that would not fade. The product promised “brightening.” What I did not realize is that most tranexamic acid studies were done on melasma, a different kind of hyperpigmentation, driven by different mechanisms. My dark spot did eventually fade, but I have no idea whether the 2% tranexamic acid or the niacinamide in the same product or just time did the work.

Tranexamic acid is a real ingredient with real clinical data. The data is mostly about one condition, at concentrations that may or may not match your product.

The export story

In Korea’s domestic cosmetic market, the functional cosmetic system has a whitening category. Products that claim to whiten or lighten skin must submit efficacy data to the Ministry of Food and Drug Safety (MFDS). Tranexamic acid is not currently on the MFDS list of approved whitening functional ingredients, so a Korean product containing tranexamic acid alone cannot carry the regulated “whitening” claim domestically. It can, however, say “brightening” in export copy, because “brightening” is not a regulated term in any market.

This matters for two reasons. First, a Korean product with tranexamic acid that says “brightening” has not necessarily passed any efficacy review, even in Korea. The word “brightening” found a translator, but the claim never sat a test. Second, products that do carry the MFDS functional cosmetic label for whitening (using approved ingredients like niacinamide or ascorbic acid glucoside) have submitted data. Whether that data is strong is another question, but at least the homework was filed.

In the US, the FDA does not regulate “brightening” as a claim. In the EU, cosmetics cannot claim to “whiten” skin, but “brightening” and “radiance” appear freely. The label is doing different work in every market, and the bottle you are holding was probably labeled for the one where you bought it.

How it works

Tranexamic acid is a synthetic derivative of the amino acid lysine. It inhibits plasminogen activation, which in skin reduces the interaction between UV-stimulated keratinocytes and melanocytes. The result is less melanin transfer to the skin’s surface [4].

This is a different mechanism from tyrosinase inhibitors like vitamin C or arbutin, which block melanin production at an earlier step. It is also different from niacinamide, which inhibits melanosome transfer. Because the mechanisms differ, these ingredients are sometimes combined.

Worth noting: tranexamic acid was originally developed as an oral medication to reduce bleeding, not as a skincare ingredient. Its use for melasma was discovered when patients taking it orally for other conditions noticed their pigmentation improving. Topical use followed. This is a pharmaceutical compound repurposed for cosmetics, which is why the clinical data exists at all. Most cosmetic “brightening” ingredients never had a reason to enter a clinical trial in the first place.

What the research shows

Study	Form	Design	Key finding
Ebrahimi and Naeini, 2014	3% topical	60 women, RCT, 12 weeks	MASI score decreased significantly vs vehicle [1]
Kanechorn Na Ayuthaya et al., 2012	5% topical	21 patients, split-face, 12 weeks	Melanin index decreased on treated side [3]
Kim et al., 2017 (meta-analysis)	Oral and topical	11 studies pooled	Both routes improved MASI scores; oral had more data [2]

How strong is this evidence? The direction is consistent: tranexamic acid reduces hyperpigmentation in melasma patients. But the trials are small, and most studied melasma specifically, not post-inflammatory hyperpigmentation or sun spots. Whether a 2% cosmetic serum produces the same effect as a 5% formulation in a clinical trial is not established. The meta-analysis found moderate confidence but called for larger, well-designed trials [2].

The fair summary: tranexamic acid reduces hyperpigmentation in melasma trials at 2–5%. Whether a 2% cosmetic serum produces the same effect on post-inflammatory spots or sun damage is not established.

Tranexamic acid vs other brightening ingredients

Ingredient	Mechanism	Typical concentration	Stability	Evidence level
Tranexamic acid	Inhibits melanin transfer via plasminogen	2–5%	Stable in water	Moderate (melasma trials)
Niacinamide	Inhibits melanosome transfer	4–5%	Very stable	Moderate (several RCTs)
Vitamin C (L-ascorbic acid)	Inhibits tyrosinase, antioxidant	10–20%	Unstable at neutral pH	Moderate
Arbutin	Inhibits tyrosinase	1–2%	Moderate	Small trials
Alpha-arbutin	Inhibits tyrosinase	1–2%	Better than arbutin	Limited

None of these has strong evidence that it produces dramatic brightening from a cosmetic product. All show consistent but modest effects in trials [5].

Combining tranexamic acid with other actives

Because tranexamic acid works by a different pathway, it can sit alongside niacinamide or vitamin C in a routine without a known interaction. Some Korean products combine all three. There is no published evidence that the combination is more effective than any single ingredient, but there is no evidence of a harmful interaction either.

Use caution when combining with strong exfoliants (AHAs, BHAs, retinol) early on. Not because of a specific interaction with tranexamic acid, but because stacking actives increases irritation risk, especially on skin that is already sensitive or compromised.

A common K-beauty approach is a toner or essence with tranexamic acid at 2% followed by a serum with niacinamide at 4-5%. Both are water-soluble, both are stable at a similar pH range, and both layer without pilling. On paper, this is a reasonable combination. In practice, you will not know which one is doing the work, or whether either is doing more than time and sunscreen would accomplish on their own. That is the honest answer the aisle does not give you: a two-ingredient brightening stack may help, but attributing any change to the right bottle is guesswork.

What to check on the label

• Concentration. If stated, look for 2% or above, which is the range studied in trials. Many products do not state a percentage.
• Ingredient order. Tranexamic acid listed in the top half of the ingredient list suggests a meaningful amount; listed near the bottom, it may be at a trace level.
• Full name. The INCI name is “tranexamic acid.” It may also appear as “tranexamic acid solution” if dissolved before addition to the formula.
• Other brightening ingredients. Check whether the product also contains niacinamide, vitamin C derivatives or arbutin. This is not a problem, but it means you cannot attribute any effect to tranexamic acid alone.
• Fragrance and essential oils. These can cause irritation on sensitized or hyperpigmented skin. If brightening is the goal, fewer potential irritants in the formula is generally better.
• “Brightening” vs functional cosmetic labels. If you are buying a Korean product, check whether it carries the MFDS functional cosmetic mark (the small icon and category text on domestic packaging). If it does, the active ingredient has been submitted for review, though that active may be niacinamide or another approved ingredient, not tranexamic acid. If it does not, “brightening” on the front is marketing copy [6].
• Formula pH. Tranexamic acid is stable across a wide pH range, unlike L-ascorbic acid, which needs a low pH to remain active. This means it is easier to formulate and less likely to degrade in the bottle. You do not need to worry about the same pH-dependent instability that affects vitamin C serums.

Where it fits in a routine

Tranexamic acid products are typically water-based and go early in the routine: after cleansing, before heavier layers. If the product is a toner, it replaces or follows your usual toner step. If it is a serum or ampoule, it goes before emulsion or cream.

For the broader routine sequence, see our three-product K-beauty routine framework. To compare toner and serum formats, see where toner, essence and serum overlap. For more on how brightening claims differ by market, see the broader discussion of regulated vs unregulated ingredient names in how to read a Korean ingredient list.

One more thing about timing: tranexamic acid takes weeks, not days. Trials that showed results measured at 8 to 12 weeks [1] [3]. If you use a tranexamic acid product for two weeks and see no change, that is not a failure. That is the timeline. The mascot rotation would like you to switch ingredients faster than any ingredient can show you results, and tranexamic acid is no exception. Give it three months before deciding. And photograph your skin under the same lighting at the start and end of that window, because memory is a terrible instrument for measuring subtle changes in pigmentation.

Now check your brightening product. Does it state a concentration? Is it 2% or above, the range used in studies? If it does not state a percentage, check the ingredient position: tranexamic acid listed after preservatives is present for the label, not for your skin.

Check the percentage. Check the position. Expect patience, not miracles. Brightening is a slow conversation between a topical and the melanocytes beneath it, and rushing the timeline teaches you nothing except impatience.

When to see a clinician first. See a dermatologist before self-treating hyperpigmentation if the dark patches appeared suddenly, are spreading, have irregular borders, or are raised. Melasma in particular can worsen with certain products and may need prescription treatment. If you are pregnant or breastfeeding, check with your doctor before using tranexamic acid topically, as oral tranexamic acid is a medication with systemic effects.